Formulation, Optimization and Characterization of Preliminary Screening of Materials Iguratimod Loaded NLCs
Rheumatoid arthritis is treated with iguratimod. Disease-modifying anti-rheumatic medication iguratimod. Rheumatoid arthritis inflammation is reduced by improving aberrant immune response and decreasing inflammation-causing chemicals. This paper optimised Iguratimod-loaded NLC formulation using Box Behnken design. 13 randomised runs were produced for the experiment. This paper examined how independent variable levels affected response variables.
Authors
- Gupta Revathi A
- Ahire Sujeetkumar Ishwarlal
Publication Details
- Journal
- International Journal of Pharmaceutical Quality Assurance
- Published
- 2024-12-04
- DOI
- https://doi.org/10.25258/ijpqa.15.4.66
- Primary Topic
- Advanced ceramic materials synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00